Jonathan H Schatz

Associate Professor

  • 967 Citations
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Neoplasms Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
Anaplastic Large-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2019

Anaplastic Large-Cell Lymphoma

Research Output 2006 2018

  • 967 Citations
  • 24 Article
  • 1 Comment/debate
  • 1 Editorial

EIF4A inhibition: Ready for primetime?

Cunningham, T. A., Chapman, E. & Schatz, J. H., Oct 1 2018, In : Oncotarget. 9, 85, p. 35515-35516 2 p.

Research output: Contribution to journalEditorial

Drug Discovery
2 Citations (Scopus)

Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas

Puvvada, S. D., Guillen-Rodriguez, J., Kumar, A., Inclán, L., Heard, K., Rivera, X. I., Anwer, F., Schatz, J. H., Mahadevan, D. & Persky, D. O., Jan 1 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 1, p. 58-64 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
2 Citations (Scopus)

Statins enhance efficacy of venetoclax in blood cancers

Lee, J. S., Roberts, A., Juarez, D., Vo, T. T. T., Bhatt, S., Herzog, L. O., Mallya, S., Bellin, R. J., Agarwal, S. K., Salem, A. H., Xu, T., Jia, J., Li, L., Hanna, J. R., Davids, M. S., Fleischman, A. G., O'Brien, S., Lam, L. T., Leverson, J. D., Letai, A. & 2 othersSchatz, J. H. & Fruman, D. A., Jun 13 2018, In : Science Translational Medicine. 10, 445, eaaq1240.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Protein Prenylation
2 Citations (Scopus)

Target-based screening against eIF4A1 reveals the marine natural product elatol as a novel inhibitor of translation initiation with in vivo antitumor activity

Peters, T. L., Tillotson, J., Yeomans, A. M., Wilmore, S., Lemm, E., Jimenez-Romero, C., Amador, L. A., Li, L., Amin, A. D., Pongtornpipat, P., Zerio, C. J., Ambrose, A. J., Paine-Murrieta, G., Greninger, P., Vega, F., Benes, C. H., Packham, G., Rodríguez, A. D., Chapman, E. & Schatz, J. H., Sep 1 2018, In : Clinical Cancer Research. 24, 17, p. 4256-4270 15 p.

Research output: Contribution to journalArticle

Biological Products
DEAD-box RNA Helicases
Adenosine Triphosphatases
1 Citations (Scopus)

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Puvvada, S. D., Guillén-Rodríguez, J. M., Yan, J., Inclán, L., Heard, K., Rivera, X. I., Anwer, F., Mahadevan, D., Schatz, J. H. & Persky, D. O., Feb 22 2018, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journalArticle

Follicular Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy